Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection
- 13 March 2011
- journal article
- basic science
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 25 (5), 611-617
- https://doi.org/10.1097/qad.0b013e328343489e
Abstract
Objectives: HIV-1 V3 quasispecies was analyzed by ultra-deep pyrosequencing, in early HIV-infected patients, to assess possible correlations between quasispecies diversity, frequency of variants predicted to use CXCR4 and need for early antiretroviral treatment. Methods: Twenty patients were retrospectively enrolled: 10 patients (group A) required HAART within 6 months from seroconversion and 10 (group B) remained free of therapy during this period. V3 quasispecies was assessed on plasma viral RNA and in peripheral blood mononuclear cell-associated proviral DNA. Prediction of coreceptor usage was performed by position-specific score matrix analysis. Results: Variants predicted to use CXCR4 were detected (frequency ≥0.3%) in the plasma of 50% of early infected patients (60% from group A and 40% from group B). Intrapatient frequency of these variants was highly variable (0.3–56.3%). A positive correlation was observed between the proportion of X4 variants and intrapatient quasispecies diversity. Quasispecies diversity and absolute numbers of X4 variants were significantly higher in patients from group A. The analysis of proviral DNA quasispecies, performed in a subgroup of five patients, showed that X4 variants were not detected in patients with RNA frequency below 0.3%, and detected at 3.6% in the patient with 56.3% of X4 plasma variants. Conclusion: Our findings show that X4 variants may be frequently found, at variable intrapatient frequency, in early infected patients, and that quasispecies diversity and absolute numbers of X4 variants are significantly higher in patients undergoing early antiretroviral treatment. Further studies are mandatory to explore the clinical relevance of X4 variants present during early infection with respect to clinical progression and possible therapeutic implications.Keywords
This publication has 26 references indexed in Scilit:
- Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- HIV‐1 Tropism, Disease Progression, and Clinical ManagementThe Journal of Infectious Diseases, 2008
- Emergence and Persistence of CXCR4‐Tropic HIV‐1 in a Population of Men from the Multicenter AIDS Cohort StudyThe Journal of Infectious Diseases, 2008
- The Impact of HIV Tropism on Decreases in CD4 Cell Count, Clinical Progression, and Subsequent Response to a First Antiretroviral Therapy RegimenClinical Infectious Diseases, 2008
- Baseline HIV Type 1 Coreceptor Tropism Predicts Disease ProgressionClinical Infectious Diseases, 2007
- HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211Clinical Infectious Diseases, 2007
- Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive IndividualsThe Journal of Infectious Diseases, 2005
- Epidemiology and Predictive Factors for Chemokine Receptor Use in HIV‐1 InfectionThe Journal of Infectious Diseases, 2005
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997
- Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDSAnnals of Internal Medicine, 1993